Mölnlycke Hibiclens Antiseptic Antimicrobial Skin Cleanser — 4% CHG Chlorhexidine Skin Prep Solution

Mölnlycke Hibiclens is a 4% chlorhexidine gluconate (CHG) antiseptic skin cleanser designed for healthcare-grade skin antisepsis and infection prevention protocols. It is used for pre-procedure cleansing, routine patient bathing, and standardized hospital hygiene workflows where reduction of skin surface microorganisms is required.

This product functions as a rinse-off antimicrobial cleanser that binds to the skin and continues providing residual antiseptic activity after application, supporting consistent clinical skin decontamination practices in both facility and home-care environments.

Clinical Decision Summary

Key Features

• 4% chlorhexidine gluconate (CHG) antiseptic formulation
• Broad-spectrum antimicrobial skin cleansing activity
• Supports pre-operative and procedural skin prep protocols
• Binds to skin for extended antiseptic activity after rinsing
• Compatible with hospital infection prevention workflows
• Liquid rinse-off cleanser format for full or targeted body use
• Non-sterile antiseptic skin preparation solution

Quick Summary

• Product Type: Antiseptic skin cleanser (CHG 4%)
• Primary Use: Skin decontamination / infection prevention
• Clinical Setting: Surgical prep, hospital bathing, LTC protocols
• Not a Dressing: No wound coverage or absorption function

What Is This Product?

Hibiclens is a chlorhexidine gluconate-based antiseptic skin cleanser formulated for reducing microorganisms on intact skin as part of infection prevention protocols. The 4% CHG active ingredient provides broad antimicrobial activity and is commonly integrated into standardized hospital bathing and surgical preparation workflows.

It is not a wound dressing or absorbent material and is intended strictly for external skin cleansing prior to or during clinical care procedures.

Indications / Clinical Applications

• Pre-operative surgical skin preparation
• Pre-procedure antiseptic skin cleansing
• Daily patient bathing in infection prevention programs
• Hospital-acquired infection (HAI) reduction protocols
• Skin decolonization programs (facility dependent)

Not intended for: open wound bed treatment, wound coverage, or absorbent dressing use.

How It Works

Chlorhexidine gluconate (CHG) acts by disrupting microbial cell membranes on the skin surface, reducing bacterial load and helping support infection prevention protocols. The formulation binds to the stratum corneum and continues to provide residual antimicrobial activity after rinsing.

This sustained binding effect is what differentiates CHG cleansers from standard soaps, making it suitable for pre-surgical and clinical hygiene protocols requiring prolonged antimicrobial activity.

Application Instructions

• Apply to wet skin per institutional protocol
• Lather thoroughly over required treatment areas
• Allow brief contact time per clinical guidelines
• Rinse completely with water
• Dry using clean or sterile procedure protocols as required

Dressing / Change Guidance

Not applicable. This product is a skin cleanser only and does not function as a dressing. Frequency of use should follow clinical protocol or infection prevention guidelines.

Why Choose This Product

Provides standardized antiseptic skin cleansing using a clinically established 4% CHG formulation. Supports consistent infection control workflows across surgical, acute care, and long-term care environments.

Designed for integration into hospital-grade hygiene protocols where consistent microbial reduction on intact skin is required.

Compare Related Categories

• /pages/wound-care
• /collections/wound-cleansers
• /collections/antiseptic-skin-prep
• /collections/infection-control-products
• /collections/medical-soaps-and-cleansers

Call to Action

Support for both home care and healthcare facility ordering is available. Call 1-866-218-0902 for product selection, bulk purchasing, and clinical support.